Urinary nucleosides

Mass Spectrometry Reviews

Volumn 17, Issue 3, 1998, Pages 131-251

  Schram, Karl H ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

AIDS; Cancer; Mass spectrometry; Modified nucleosides; SCID; Urinary nucleosides

Indexed keywords

NUCLEOSIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; HUMAN; MASS FRAGMENTOGRAPHY; METHODOLOGY; NEOPLASM; REVIEW; URINE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; NEOPLASMS; NUCLEOSIDES;

EID: 0032057381     PISSN: 02777037     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2787(1998)17:3<131::AID-MAS1>3.0.CO;2-O     Document Type: Article

References (113)

1. Adams, W. S.; Davis, F.; Nakatani, M. Purine and pyrimidine excretion in normal and leukemic subjects. Am J Med 1960, 28, 726-734.
2. Adler, M.; Gutman, A. B. Uridine isomer (5-ribosyluracil) in human urine. Science 1959, 130, 862-863.
3. AMA, An Historical Sketch of the Clinical Examination of Urine; Lecture Memoranda: Los Angeles; Burroughs Wellcome: London, 1911; p 12.
4. Apell, G.; Buschman, F. L.; Sharma, O. K. Improved and rapid method for quantiation of modified nucleosides in urine and sera with Radial-Pak cartridge. J Chromatogr 1986, 374, 149-154.
5. Applegarth, D. A.; Hardwich, D. F.; Ingram, F.; Auckland, N. L.; Bozoian, G. Excretion of s-adenosylmethionine and s-adenosylhomocysteine in homocystinurea. N Engl J Med 1971, 285, 1265-1266.
6. Arient; Dienstbier; Sejbal. Fis Sanit Radioprot Radiaz 1966, 10; Chem Abstr 67 61372c.
7. Basile, B.; Scott, M. F.; Hsu, F.-F.; McCloskey, J. A. Mass Spectra of Bases, Nucleosides, Nucleotides and Their Derivatives; Dept Med Chem Biochem: University of Utah, 1981.
8. Beardmore, T. D.; Kelley, W. N. Ultraviolet-absorbing compounds in urine from patients with hereditary disorders of purine and pyrimidine metabolism. Clin Chem 1971, 17, 795-801.
9. Borek, E.; Baliga, B. S.; Gehrke, C. W.; Kuo, K. C.; Belman, S.; Troll, W.; Waalkes, T. P. High turnover rate of transfer RNA in tumor tissue. Canc Res 1977, 37, 3362-3366.
10. Borek, E.; Kerr, S. Atypical transfer RNAs and their origin in neoplastic cells. Adv Cancer Res 1972, 15, 163-190.
11. Borek, E.; Sharma, O. K.; Buschman, F. L.; Cohn, D. L.; Penley, K. A.; Judson, F. N.; Dobozin, B. S.; Horsburgh, C. R. Jr.; Kirkpatrick, C. H. Altered excretion of modified nucleosides and (-aminoisobutyric acid in subjects with acquired immunodeficiency syndrome or at risk of acquired immunodeficiency syndrome. Canc Res 1986, 46, 2557-2561.
12. Borek, E.; Sharma, O. K.; Waalkes, T. P. New applications of urinary nucleoside markers. Rec Results Canc Res 1983, 84, 301-316.
13. Chang, M. L. W.; Johnson, B .S. J Biol Chem 1961, 236, 2096.
14. Chang, S. Y.; Lakings, D. B.; Zumwalt, R. W.; Gehrke, G. W. Quantitative determination of methylated nucleosides and pseudouridine in urine by gas-liquid chromatography. J Lab Clin Med 1974, 83, 816-830.
15. Chantin, C.; Bonin, B.; Boulieu, R.; Bory, C. Liquid-chromatographic study of purine metabolism abnormalities in purine nucleoside phosphorylase deficiency. Clin Chem 1996, 42, 326-328.
16. Chheda, G. B. Isolation and characterization of a novel nucleoside, N-[(9-β-D-ribofuranosyl-9H-purin-6-yl)carbamoyl]threonine, from human urine. Life Sci 1969, 8, 979-987.
17. rd Ed.; Chemical Rubber: Cleveland, OH, 1975; pp 251-270.
18. 6-succinyladenosine from human urine. Nucleic Acids Res 1977, 4, 739-746.
19. Chheda, G. B.; Antkowiak, J. G.; Takita, H.; Bhargava, A. K.; Tworek, H. A. Internat Symp Anal Nucleoside, Nucleotide and Oligonucleotide Comp: Antwerp, Belgium, Sept. 1989.
20. Chheda, G. B.; Dutta, S. P.; Mittelman, A.; Montgomery, J. A.; Sethi, S. K.; McCloskey, J. A.; Patrzyc, H. B. Isolation and characterization of a novel nucleoside, 7-β-D-ribofuranosylhypoxanthine, from the urine of a chronic myelogenous leukemia patient. Canc Res 1985, 45, 5958-5963.
21. Chheda, C. B.; Dutta, S. P.; Tworek, H. A.; Bhargava, A. K.; Takita, H.; Antkowiak, J. G.; Patrzyc, H. B. Isolation and characterization of an unusual nucleoside from human urine. Nucleosides Nucleotides 1995, 14, 1519-1537.
22. 2-isopentenyl)adenosine metabolism in man. Biochem Pharmacol 1972, 21, 27-37.
23. 2-methylguanosine from normal human urine. J Pharm Sci 1969, 58, 75-78.
24. Chheda, G. B.; Patrzyc, H. B.; Bhargava, A. K.; Crain, P. F.; Sethi, S. K.; McCloskey, J. A.; Dutta, S. P. Isolation and characterization of a novel nucleoside from the urine of chronic myelogenous leukemia patients. Nucleosides Nucleotides 1987, 6, 597-611.
25. Chheda, G .B.; Patrzyc, H. B.; Tworek, H. A.; Dutta, S. P. In: Gehrke, C. W.; Kuo, K. C. T., editors; Isolation and characterization of modified nucleosides from human urine. Chromatography and Modification of Nucleosides, Part C; Elsevier: Amsterdam, 1990; pp C185-C230.
26. th ASMS Conf Mass Spectro Allied Topics: San Francisco, CA, June 1988; pp 492-493.
27. Chheda, G. B.; Tworek, H. A.; Bhargava, A. K.; Rachlin, E.; Dutta, S. P.; Patrzyc, H. B. Isolation and characterization of 3-(3-amino-3-carboxypropyl)uridine from human urine. Nuclosides Nucleotides 1988, 7, 417.
28. D'Ambrosio, S. M.; Gibson - D'Ambrosio, R. E.; Trewyn, R. W. An enzyme-linked immunosorbent assay (ELISA) for the detection and quantisation of the tumor marker 1-methylinosine in human urine. Clin Chim Acta 1991, 199, 119-128.
29. Dunn, D. B. Additional components in ribonucleic acid of rat-liver fractions. Biochim Biophys Acta 1959, 34, 286-287.
30. Dutta, S. P.; Crain, P. F.; McCloskey, J. A.; Chheda, G. B. Isolation and characterization of 1-β-d-ribofuranosylpyridin-4-one-3-carboxamide from human urine. Life Sci 1979, 24, 1381-1387.
31. Dutta, S. P.; Tworek, H. A.; Bhargara, A. K.; Patrzyc, H. B.; Chheda, G. B. Characterization of 2′-O-methylinosine and other 2′-O-methylnucleosides in human urine. 36th ASMS Conf Mass Spectrom Allied Topics: San Francisco, CA, June 1998; pp 494-495.
32. Esmans, E. L.; Geboes, P.; Luyten, Y.; Alderweireldt, F. C. Direct liquid introduction LC/MS micorbore experiments for the analysis of nucleoside material present in human urine. Biomed Mass Spectrom 1985, 12, 241-245.
33. Fink, K.; Adams, W. S. Urinary purines and pyrimidines in normal and leukemic subjects. Arch Biochem Biophys 1968, 126, 27-33.
34. Fink, K.; Adams, W. S.; Davis, F.W.; Nakatani, M. The identification of 2-di-methylamino-6-hydroxypurine and its ribonucleoside in urine of normal and leukemic subjects. Cancer Res 1963, 23, 1824-1829.
35. Fischbein, A.; Valciukas, J. A.; Buschman, F.; Kohn, M.; Teirstein, A.; Borek, E.; Sharma, O. K.; Bekesi, J. G.; Apell, G.; Boesch, R. R.; Selikoff, I. J. Urinary excretion of modified nucleosides in patients with acquired immune deficiency syndrome (AIDS) and individuals at high risk of AIDS. Canc Detect Prevent 1985, 8, 217-277.
36. Gehrke, C. W.; Kuo, K. C., editors; Chromatography and Modification of Nucleosides; Elsevier: New York, 1990.
37. Gehrke, C. W.; Kuo, K. C. Ribonucleoside analysis by reversed-phase high performance liquid chromatography. In: Gehrke, C. W.; Kuo, K. C., editors; Chromatography and Modification of Nucleosides; Elsevier: New York, 1990; pp A3-A73.
38. Gehrke, C. W.; Kuo, K. C.; Davis, G. E.; Suits, R. D.; Waalkes, T. P.; Borek, E. Quantitative high-performance liquid chromatography of nucleosides in biological fluids. J Chromatogr 1978, 150, 455-476.
39. Gehrke, C. W.; Kuo, K. C.; Waalkes, T. P.; Borek, E. Patterns of urinary excretion of modified nucleosides. Canc Res 1979, 39, 1150-1153.
40. Gehrke, C. W.; Zumwalt, R. W.; McCune, R. A.; Kuo, K. C. Quantitative high performance liquid chromatography analysis of modified nucleosides in physiological fluids, tRNA and DNA. Rec Results Canc Res 1983, 84, 344-359.
41. Graff, L. A Handbook of Routine Urinalysis, J.B. Lippincott: Philadelphia, 1983.
42. Hall, R. H. A general procedure for the isolation of minor nucleosides from ribonucleic acid hydrolysates. Biochem 1965, 4, 661-670.
43. Hammargren, W. M.; Luffer, D. R.; Schram, K. H.; Reimer, M. L. J.; Nakano, K.; Yasaka, T. Moorman, A. R. The identification of 5′-deoxy-5′-methylthioguanosine in human urine by gas chromatography/mass spectrometry. Nucleosides Nucleotides 1992, 11, 1275-1292.
44. 6-dimethyladenosine, in human cancer urine. Anal Chim Acta 1991, 247, 201-209.
45. Heirwegh, X.; Ramboer, X.; Groote, X. Am J Med 1967, 42, 913.
46. Heldman, D. A.; Grever, M. R.; Speicher, C. E.; Trewyn, R. W. Urinary excretion of modified nucleosides in chronic myelogenous leukemia. J Lab Clin Med 1983, 101, 783-792.
47. Heldman, D. A.; Grever, M. R.; Trewyn, R. W. Differential excretion of modified nucleosides in adult acute leukemia. Blood 1983, 61, 291.
48. Hirschhorn, R. In: Schwartz, R. S., editor. Defects of purine metabolism in immunodeficiency diseases. Progress in Clinical Immunology, Vol. III; Grune & Stratton: New York, 1977; pp 67-83.
49. Hirschhorn, R.; Ratech, H.; Rubinstein, A.; Papageorgiou, P.; Kesarwals, H.; Gelfand, E.; Roegner - Maniscalco, V. Increased excretion of modified adenine nucleosides by children with adenosine deaminase deficiency. Pediatr Res 1982, 16, 362-369.
50. Itoh, K.; Aida, S.; Ishiwata, S.; Sasaki, S.; Ishida N.; Mizugaki, M. Urinary excretion patterns of modified nucleosides, pseudouridine and 1-methyladenosine, in healthy individuals. Clin Chim Acta 1993, 217, 221-223.
51. Itoh, K.; Aida, S.; Ishiwata, S.; Yamaguchi, T.; Ishida, N.; Mizugaki, M. Immunochemical detection of urinary 5-methyl-2′-deoxycytidine as a potential biologic marker for leukemia. Clin Chim Acta 1995, 234, 37-45.
52. Itoh, K.; Konno, T.; Sasaki, T.; Ishiwata, S.; Ishida, N. Relationship of urinary pseudouridine and 1-methyladenosine to activity of leukemia and lymphoma. Clin Chim Acta 1992, 206, 181-189.
53. Itoh, K.; Mizugaki, M.; Ishida, N. Jpn J Canc Res (Gann) 1988, 79, 1130-1138.
54. Koshida, K.; Harmenberg, J.; Stendahl, U.; Wahren, B.; Borgstrom, E.; Helstrom, L.; Andersson, L. Urinary modified nucleosides as tumor markers in cancer of the urinary organs or female genital tract. Urol Res 1985, 13, 213-218.
55. Kruger M.; Salomon, G. Die alloxurbasen des Harnes. Ztschr f physiol Chem 1898, 24, 364.
56. Kruger M.; Salomon, G. Die alloxurbasen des Harnes. Ztschr f physiol Chem 1898, 26, 350.
57. Kuo, K .C.; Esposito, F.; McEntire, J. E.; Gehrke, C. W. Nucleoside profiles by HPLC-UV in serum and urine of controls and cancer patients. In: Cimino, F.; Birkmayer, G. D.; Klavins, J. V.; Pimentai, E.; Salvatore, F., editors; Human Tumor Markers; Walter de Gruyter: Berlin, 1987; pp 519-544.
58. Langridge, J. L.; McClure, T. D.; El-Shakawi, S.; Fielding, A.; Schram, K. H.; Newton, R. P. Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumor markers. Rap Comm Mass Spectrom 1993, 7, 427-434.
59. Liebich, H. M.; Stefano, C. D.; Wixforth, A.; Schmid, H. R. Quantitation of urinary nucleosides by high-performance liquid chromatography. J Chromatogr 1997, 763, 193-197.
60. Limbach, P. A.; Crain, P. F.; McCloskey, J. A. Summary: the modified nucleosides of RNA. Nucleic Acids Res 1994, 22, 2183-2196.
61. Mandel, L.; Borek, E. The biosynthesis of methylated bases in ribonucleic acid. Biochem 1963, 2, 555-560.
62. Mandel, L. R.; Srinivasan, P. R.; Borek, E. Origin of urinary methylated purines. Nature 1966, 20, 586-588.
63. Manjula, S.; Aroor, A. R.. Raja, A.. Rao, S.. Rao, A. Urinary excretion of pseudouridine in patients with brain tumors. Acta Oncologica 1993, 3, 311-314.
64. Markiw, R. T. Isolation and identification of 3-methyluridine from normal human urine. Biochem Med 1973, 8, 182-187.
65. Masuda, M.; Nishihira, T.; Itoh, K.; Mizugaki, M.; Ishida, N.; Mori, S. An immunohistochemical analysis for cancer of the esophagus using monoclonal antibodies specific for modified nucleosides. Cancer 1993, 72, 3571-3578.
66. McCloskey, J.A. In: T'so, P. O. P., editor; Basic Principles of Nucleic Acid Chemistry; Academic: New York, 1974; pp 209-309.
67. McClure, T. D.; Schram, K.H. In: Desiderio, D. M., editor; Analysis of urinary nucleosides. Mass Spectrometry: Clinical and Biomedical Applications, Vol. 2; Plenum Press: New York, 1994, pp 201-236.
68. 68.(a) McClure, T .D.; Schram, K. H.; Nakano, K.; Yasaka, T. Identification and synthesis of 5′-deoxyxanthosine, a novel nucleoside in normal human urine. Nucleosides Nucleotides 1989, 8, 1399-1415.
69. 68.(b) McClure, T. D.; Schram, K. H.; Nakano K.; Yasaka, T. 3-Methyluridine in normal human urine. Nucleosides Nucleotides 1989, 8, 1399-1415.
70. Mills, G. C. Urinary purines, pyrimidines and nucleosides in undine-treated orotic aciduria. Clin Chim Acta 1988, 174, 337-344.
71. Mills, G. C.; Davis, N. H.; Lertratanangkoon, K. Isolation and identification of 1-ribosylpyridone. Nucleosides Nucleotides 1989, 8, 415-430.
72. Mills, G. C; Mills, J .S. Urinary excretion of methylthioadenosine in immunodeficient children. Clin Chim Acta 1985, 147, 15-23.
73. Mills, G. C.; Schmalsteig, F. C.; Goldblum, R. M. Urinary excretion of modified purines and nucleosides in immunodeficient children. Biochem Med 1985, 34, 37-51.
74. Mills, J .S.; Mills, G. C.; McAdoo, D. J. Isolation and identification of 5′-methylthioadenosine sulfoxide from human urine. Nucleosides Nucleotides 1983, 2, 465-478.
75. Morris, G. S.; Simmonds, H. A.; Davies, P. M. Use of biological fluids for the rapid diagnosis of potentially lethal inherited disorders of human purine and pyrimidine metabolism. Biomed Chromatogr 1986, 1, 109-118.
76. Mrochek, J. E.; Dinsmore, S. R.; Waalkes, T. P. Analytic techniques in the separation and identification of specific purine and pyrimidine degradation products of tRNA: application to urine samples from cancer patients. J Natl Canc Inst 1974, 53, 1553-1563.
77. Nakano, K.; Nakao, T.; Schram, K. H.; Hammargren, W. M.; McClure, T. D.; Katz, M.; Petersen, E. Urinary excretion of modified nucleosides as biological marker of RNA turnover in patients with cancer and AIDS. Clin Chim Acta 1993, 218, 169-183.
78. Nakano, K. Shindo, K. Yasaka, T. Reversed-phase high-performance liquid chromatographic investigation of mucosal nucleosides and bases and urinary modified nucleosides of gastrointestinal cancer patients. J Chromatogr 1985, 343, 21-33.
79. Nass, G., editor; Recent Results in Cancer Research; Springer - Verlag: Berlin, 1982.
80. Nielsen, H. R.; Killmann, S.-A. Urinary excretion of (-aminoisobutyrate and pseudouridine in acute and chronic myeloid leukemia. J Natl Canc Inst 1983, 71, 887-891.
81. Oerlemans, F. Lange, F. Major and modified nucleosides as markers in ovarian cancera - a pilot study. Gynecol Obstet Invest 1986, 22, 212-217.
82. Oppenheimer, N. J.; Kaplan, N. O. The alpha beta epimerization of reduced nicotinamide adenine dinucleotide. Arch Biochem Biophys 1975, 166, 526-535.
83. Pang, H.; Schram, K. H.; Smith, D. L.; Gupta, S. P.; Townsend, L. B.; McCloskey, J. A. Mass spectrometry of nucleic acid constitutents. Trimethylsilyl derivatives of nucleosides. J Org Chem 1982, 47, 3923-3932.
84. Prankel, B. H.; Clemens, P. C.; Burmester, J. G. Urinary excretion of nucleosides varies with age and protein metabolism. Clin Chim Acta 1995, 234, 181-183.
85. Rasmuson, T.; Bjork, G. R. Acta Urinary excretion of pseudouridine and prognosis of patients with malignant lymphoma. Oncolog 1995, 1, 61-67.
86. Reimer, M. L.; McClure, T. D.; Schram, K. H. Differentiation of 2′-, 3′-, and 5′-deoxyribonucleosides using electron ionization and chemical ionization linked scanning mass spectrometry. Biomed Environ Mass Spectrom 1989, 18, 533-543.
87. Reimer, M. L.; Schram, K. H.; Nakano, K.; Yasaka, T. The identification of 5,6-dihydrouridine in normal human urine by combined gas chromatography/mass spectrometry. Anal Biochem 1989, 181, 302-308.
88. Reynaud, C.; Bruno, C.; Boullanger, P.; Grange, J.; Barbesti, S.; Niveleau, A. Monitoring of urinary excretion of modified nucleosides in cancer patients using a set of six monoclonal antibodies. Canc Lett 1991, 255-262.
89. Ruddon, R. W. In: Ruddon, R. W., editor. Role of biological markers in cancer diagnosis and treatment. Biological Markers of Neoplasia: Basic and Applied Aspects; Elsevier - North Holland: New York, 1978; pp 1-7.
90. Sander, G.; Hulsemann, J.; Topp, H. Protein and RNA turnover in preterm infants and adults: a comparison based on urinary excretion of 3-methylhistidine and of modified oneway RNA-catabolites. Ann Nutr Metab 1986, 30, 137-142.
91. Sasco, A. J.; Rey, F.; Reynaud, C.; Bobin, J.-Y.; Clavel, M.; Niveleau, A. Breast cancer prognostic significance of some modified urinary nucleosides. Canc Let 1996, 108, 157-162.
92. Schlimme, E.; Boos, K.-S.; Wilmers, B.; Gent, H. J. Analysis of ribonucleosides in human body fluids and their possible role as pathobiochemical markers.In: Cimino, F.; Birkmayer, G. D.; Clavins, J. V.; Pimentel, E.; Salvatore, F., editors. Human Tumor Markers; Walter de Gruyter: Berlin, 1987; PP 503-517.
93. Schoch, G.; Thomale, J.; Lorenz, H.; Suberg, H.; Karsten, U-A new method for the simultaneous analysis of unmodified and modified urinary nucleosides and nucleobases by high performance liquid chromatography. Clin Chim Acta 1980, 108, 247-257.
94. Schoch, G.; Winkler, K.; Heller - Schoch, G.; Baisch, H. Die analyse von normalen and methylierten nucleobasen im urin als neues kriterium fur diagnose and verlauf von malignomen. Klin Paediatr 1979, 191, 197-204.
95. Schram, K. H.; unpublished data.
96. Schram, K.H. In: McCloskey, J. A., editor. Preparation of trimethylsilyl derivatives of nucleic acid components for analysis by mass spectrometry. Methods in Enzymology, Vol. 193; Academic: San Diego, 1990; pp 791-796.
97. Solomon, S. J.; Fischbein, A.; Sharma, O. K.; Borek, E. Modified nucleosides in asbestos workers at high risk of malignant disease: results of preliminary study applying discriminant analysis. Brit J Indust Med 1985, 42, 560-562.
98. Sox, H. C., editor. Common Diagnostic Tests: Use and Interpretation; American College of Physicians: Philadelphia, 1987.
99. Stryer, L. Biochemistry, third edition; Freeman: New York, 1988; p 713.
100. Tamura, S.; Fujii, J.; Nakano, T.; Hada, T.; Higashino, K. Urinary pseudouridine as a tumor marker in patients with small cell lung cancer. Clin Chim Acta, 1986, 154, 125-132.
101. Tormey, D. C.; Waalkes, T. P.; Ahmann, D.; Gehrke, C. W.; Zumwatt, R. W.; Snyder, J.; Hansen, H. Biological markers in breast carcinoma. Cancer 1975, 35, 1095-1100.
102. Trewyn, R. W.; Grever, M. R. Urinary nucleosides in leukemia: laboratory and clinical applications. Crit Rev Clin Lab Sci 1986, 24, 71-93.
103. Trewyn, R. W.; Glaser, R.; Kelly, D. R.; Jackson, D. G.; Graham, W. P.; Speicher, C. E. Elevated nucleoside excretion by patients with nasopharyngeal carcinoma. Cancer 1982, 49, 2513-2517.
104. Tuttle, J. V.; personal communication.
105. Tworek, H. A.; Bolanowska, W.; Bhargava, A. K.; Rachlin, E. M.; Chheda, G. B. Isolation and characterization of a novel nucleoside from human cancer urines. Nucleosides Nucleotides 1986, 5, 253-263.
106. 6-acetylcytidine from normal human urines. J Carbohyd Nucleosides Nucleotides 1978, 5, 235-249.
107. 2-isopentenyl)adenosine and 2′-O-methylguanosine as determined by radioimmunoassay for normal subjects and cancer patients. Canc Res 1982, 42, 5265-5269.
108. Void, B. S.; Kraus, L. E.; Rimer, V. G.; Coombes, R. C. Use of a monoclonal antibody to detect elevated levels of a modified nucleoside,N-[9-β-D-ribofuranosyl)-purin-6-ylcarbamoyl]-L-threonine, in the urine of breast cancer patients. Canc Res 1986, 46, 3164-3167.
109. von Minden, D. L.; Stillwell, R. N.; Koenig, W. A.; Lyman, K. J.; McCloskey, J. A. Mass spectrometry of 7-methylpurine nucleosides: studies of a characteristic oxygen incorporation reaction that occurs during trimethylsilylation. Anal Biochem 1972, 50, 110-121.
110. Vreken, P.; Tavenier, P. Urinary excretion of six modified nucleosides by patients with breast carcinoma. Ann Clin Biochem 1987, 24, 598-603.
111. Waalkes, T. P.; Abeloff, M. D.; Ettinger, D. S.; Woo, K. B.; Gehrke, C. W.; Kuo, K. C.; Borek, E. Modified ribonucleosides as biological markers of patients with small cell carcinoma of the lung. Eur J Cancer Clin Oncol 1982, 18, 1267-1274.
112. Waalkes, T. P.; Gehrke, C. W.; Zumwalt, R. W.; Chang, S. Y.; Lakings, D. B.; Tormey, D. C.; Ahmann, D. L.; Moertel, C. G. The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancer. Cancer 1975, 36, 390-398.
113. Weissmann, S. M.; Eisen, A. Z.; Karon, M. Pseudouridine metabolism. IV. Excretion of pseudouridine and other nitrogenous metabolites in chronic leukemia. Blood 1963, 22, 657.